Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02338349
Title A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Radius Pharmaceuticals, Inc.

breast adenocarcinoma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.